AN2 Therapeutics, Inc. Shares Outstanding
AN2 Therapeutics, Inc. (ANTX) had Shares Outstanding of 36.31 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-11
- 2026-06-30: Shares outstanding (split-adjusted) 36.31M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 35.99M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 27.41M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 27.37M shares; Shares authorized (split-adjusted) 500.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 36.31M shares 10-Q · filed 2026-08-11 | 500.00M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 35.99M shares 10-Q · filed 2026-05-11 | 500.00M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 27.41M shares 10-Q · filed 2026-08-11 | 500.00M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 27.37M shares 10-Q · filed 2025-11-12 | 500.00M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 27.38M shares 10-Q · filed 2025-08-12 | 500.00M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 30.14M shares 10-Q · filed 2025-05-13 | 500.00M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 29.92M shares 10-K · filed 2026-03-17 | 500.00M shares 10-K · filed 2026-03-17 |
| 2024-09-30 | 29.87M shares 10-Q · filed 2024-11-13 | 500.00M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 29.83M shares 10-Q · filed 2024-08-13 | 500.00M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 29.82M shares 10-Q · filed 2024-05-14 | 500.00M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 29.74M shares 10-K · filed 2025-03-25 | 500.00M shares 10-K · filed 2025-03-25 |
| 2023-09-30 | 29.74M shares 10-Q · filed 2023-11-09 | 500.00M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 21.93M shares 10-Q · filed 2023-08-10 | 500.00M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 19.43M shares 10-Q · filed 2023-05-11 | 500.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 19.40M shares 10-K · filed 2024-03-29 | 500.00M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 19.40M shares 10-Q · filed 2022-11-09 | 500.00M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 19.40M shares 10-Q · filed 2022-08-11 | 500.00M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 18.71M shares 10-Q · filed 2022-05-10 | 500.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 2.73M shares 10-K · filed 2023-03-29 | 17.17M shares 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |